153 related articles for article (PubMed ID: 26058565)
1. Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety.
Redko B; Ragozin E; Andreii B; Helena T; Amnon A; Talia SZ; Mor OH; Genady K; Gary G
Biopolymers; 2015 Nov; 104(6):743-52. PubMed ID: 26058565
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
[TBL] [Abstract][Full Text] [Related]
3. New somatostatin-drug conjugates for effective targeting pancreatic cancer.
Ragozin E; Hesin A; Bazylevich A; Tuchinsky H; Bovina A; Shekhter Zahavi T; Oron-Herman M; Kostenich G; Firer MA; Rubinek T; Wolf I; Luboshits G; Sherman MY; Gellerman G
Bioorg Med Chem; 2018 Jul; 26(13):3825-3836. PubMed ID: 30017114
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor-targeted anti-cancer therapy.
Sun LC; Coy DH
Curr Drug Deliv; 2011 Jan; 8(1):2-10. PubMed ID: 21034425
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin analogs and radiopeptides in cancer therapy.
Froidevaux S; Eberle AN
Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036
[TBL] [Abstract][Full Text] [Related]
6. Investigation of cancer cell lines for peptide receptor-targeted drug development.
Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
[TBL] [Abstract][Full Text] [Related]
7. Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.
Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
Biopolymers; 2016 Mar; 106(2):160-171. PubMed ID: 26715008
[TBL] [Abstract][Full Text] [Related]
8. Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents.
Sun L; Fuselier JA; Coy DH
Drug Deliv; 2004; 11(4):231-8. PubMed ID: 15371104
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro biological activity and docking of new analogs of BIM-23052 containing unnatural amino acids.
Naydenova E; Wesselinova D; Staykova S; Danalev D; Dzimbova T
Amino Acids; 2019 Sep; 51(9):1247-1257. PubMed ID: 31350614
[TBL] [Abstract][Full Text] [Related]
10. GnRH-III based multifunctional drug delivery systems containing daunorubicin and methotrexate.
Leurs U; Lajkó E; Mező G; Orbán E; Öhlschläger P; Marquardt A; Kőhidai L; Manea M
Eur J Med Chem; 2012 Jun; 52():173-83. PubMed ID: 22480495
[TBL] [Abstract][Full Text] [Related]
11. A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.
Zheng N; Dai W; Du W; Zhang H; Lei L; Zhang H; Wang X; Wang J; Zhang X; Gao J; Zhang Q
Mol Pharm; 2012 May; 9(5):1175-88. PubMed ID: 22435704
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, in vitro stability and cytostatic effect of multifunctional anticancer drug-bioconjugates containing GnRH-III as a targeting moiety.
Leurs U; Mező G; Orbán E; Öhlschläger P; Marquardt A; Manea M
Biopolymers; 2012; 98(1):1-10. PubMed ID: 21509746
[TBL] [Abstract][Full Text] [Related]
13. Application of human pancreatic carcinoid BON cells for receptor-targeted drug development.
Sun L; Morris LM; Luo J; Mackey LV; Leslie JS; Franko-Tobin LG; Fuselier JA; LePage KT; Coy DH
J Drug Target; 2011 Sep; 19(8):666-74. PubMed ID: 21083509
[TBL] [Abstract][Full Text] [Related]
14. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells.
Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V
Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087
[TBL] [Abstract][Full Text] [Related]
15. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.
Gaviglio L; Gross A; Metzler-Nolte N; Ravera M
Metallomics; 2012 Mar; 4(3):260-6. PubMed ID: 22310724
[TBL] [Abstract][Full Text] [Related]
17. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
18. "Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.
Gilad Y; Firer MA; Rozovsky A; Ragozin E; Redko B; Albeck A; Gellerman G
Eur J Med Chem; 2014 Oct; 85():139-46. PubMed ID: 25084142
[TBL] [Abstract][Full Text] [Related]
19. Improving anticancer activity and selectivity of camptothecin through conjugation with releasable substance P.
Zhang W; Song J; Mu L; Zhang B; Liu L; Xing Y; Wang K; Li Z; Wang R
Bioorg Med Chem Lett; 2011 Mar; 21(5):1452-5. PubMed ID: 21282053
[TBL] [Abstract][Full Text] [Related]
20. Selective bone targeting 5-fluorouracil prodrugs: synthesis and preliminary biological evaluation.
Ouyang L; He D; Zhang J; He G; Jiang B; Wang Q; Chen Z; Pan J; Li Y; Guo L
Bioorg Med Chem; 2011 Jun; 19(12):3750-6. PubMed ID: 21612935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
